Rendez visite à OBiO lors du 30e congrès annuel de l’ESGCT à Bruxelles SHANGHAI, 25 octobre 2023 /PRNewswire/ — OBiO Technology (Shanghai) Corp. Ltd. (OBiO, 688238.SH), un leader mondial dans le développement et la fabrication de produits de thérapie cellulaire et génique, a…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.